Research in cancer-associated fibroblasts of NSCLC patients suggests that IFN-γ induces anti-tumor immune responses and contributes to a better prognosis of patients by upregulating the expression of PD-L1 (35). This evidence concerns the gene CD274 and non-small cell lung carcinoma.